Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100049821Phase 4Not yet recruiting
Phase 4, randomised trial of granulocyte colony-stimulating factor in Endometrial hypotrophy (2 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: Endometrial thickness, Clinical pregnancy rate and 1 more. Planned start Sep 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100049821.